Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients

Table 1 Clinicopathological data of PDAC patients and cancer-free controls in proteomic analysis

No. of samples	Sex	Age	Histology*	Tumor location	Metastases
PDAC
1	female	55	Moderately differentiated ductal adenocarcinoma	Tail of pancreas	Yes
2	male	65	Well differentiated ductal adenocarcinoma	Head of pancreas	No
3	male	38	Well differentiated ductal adenocarcinoma	Head of pancreas	Yes
4	male	57	Moderately differentiated ductal adenocarcinoma	Body of pancreas	Yes
5	female	53	Poorly differentiated ductal adenocarcinoma	Head of pancreas	No
6	male	59	Moderately differentiated ductal adenocarcinoma	Head of pancreas	Yes
7	female	44	Moderately differentiated ductal adenocarcinoma	Tail of pancreas	Yes
8	female	51	Well differentiated ductal adenocarcinoma	Head of pancreas	No
9	male	48	Moderately differentiated ductal adenocarcinoma	Tail of pancreas	No
Cancer-free			Clinical diagnosis
1	male	53	Chronic pancreatitis
2	female	66	benign cystic neoplasm of pancreas
3	male	49	Gallstone pancreatitis
4	male	50	Chronic pancreatitis
5	female	52	benign cystic neoplasm of pancreas
6	female	57	benign cystic neoplasm of pancreas
7	male	46	Chronic pancreatitis
8	female	47	cystic fibrosis of pancreas
9	male	60	Chronic pancreatitis

* PDAC differentiation was classified according to the WHO standard (2nd edition, 1996).

ISSN: 1471-2407